Novartis' initial stake in Nestlé's Alcon not subject to merger control in Europe
The first stage of Novartis´ planned acquisition of Nestlé's stake in Alcon will not be notified in Brussels since the initial phase of this transaction (24.85 percent stake) does not amount...To view the full article, register now.
Already a subscriber? Click here to view full article